Clinical Trial Update: Study of IMC-S118AI in Type 1 Diabetes [Phase 1]

View source ↗

Summary

Immunocore Ltd is studying IMC-S118AI in a Phase 1 trial for Type 1 diabetes. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• IMC-S118AI

Snippet

Sponsor: Immunocore Ltd | Conditions: Type 1 Diabetes, Type 1 Diabetes (T1D) | Phase 1 | Status: NOT_YET_RECRUITING